2247669-96-9

2247669-96-9 structure

Name: Cofirasersen
Chemical Name: Cofirasersen
CAS Number: 2247669-96-9
Molecular Formula: C₁₇₂H₂₁₈N₅₇O₈₈P₁₅S₁₅
Molecular Weight: 5437.55
Catalog: Signaling Pathways Membrane Transporter/Ion Channel Sodium Channel
Create Date: 2023-06-03 22:30:11
Modify Date: 2024-01-10 19:23:14
Cofirasersen is designed to reduce the expression of ENaC in the lung. ENaC is a sodium transport channel and believed to be hyperactive in cystic fibrosis, which is caused by mutations in the cystic fibrosis transmembrane regulator gene.

Name	Cofirasersen

Description	Cofirasersen is designed to reduce the expression of ENaC in the lung. ENaC is a sodium transport channel and believed to be hyperactive in cystic fibrosis, which is caused by mutations in the cystic fibrosis transmembrane regulator gene.
Related Catalog	Signaling Pathways >> Membrane Transporter/Ion Channel >> Sodium Channel Research Areas >> Others
References	[1]. WHO Drug Information, Vol. 34, No. 3, 2020

Molecular Formula	C₁₇₂H₂₁₈N₅₇O₈₈P₁₅S₁₅
Molecular Weight	5437.55